Loading…
Neuland Laboratories (NEULANDLAB)₹20,322+2.45%Pharmaceuticals
At the end of the Jun 2026 quarter, Neuland Laboratories' shareholders were: promoters 32.66%, FIIs 21.06%, DIIs 16.56%, public 29.72%. Promoter holding is down 0.01 percentage points from 32.67% a quarter earlier. FII holding is down 0.61 percentage points from 21.67% a year earlier. 2.30% of promoter shares were pledged. It had 44,325 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 36.01% | 32.84% | 32.78% | 32.76% | 32.68% | 32.72% | 32.71% | 32.71% | 32.68% | 32.67% | 32.67% | 32.66% |
| FIIs | 21.55% | 22.67% | 24.41% | 25.70% | 26.44% | 23.84% | 22.10% | 21.67% | 20.58% | 20.88% | 20.44% | 21.06% |
| DIIs | 7.03% | 6.06% | 6.58% | 6.43% | 6.42% | 9.13% | 11.01% | 11.61% | 13.59% | 14.76% | 15.88% | 16.56% |
| Government | 0.40% | 0.40% | 0.40% | 0.40% | 0.40% | 0.40% | 0.40% | 0.40% | 0.40% | 0.00% | 0.00% | 0.00% |
| Public | 35.01% | 38.03% | 35.83% | 34.71% | 34.06% | 33.91% | 33.78% | 33.61% | 32.75% | 31.69% | 31.01% | 29.72% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 2.30% |
| Number of shareholders | 26,815 | 27,714 | 28,606 | 29,067 | 34,555 | 39,302 | 39,320 | 42,405 | 44,378 | 46,171 | 46,288 | 44,325 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Davuluri Ownership Trust (Dr. Davuluri Ramamohan Rao, Mr. Davuluri Sucheth Rao and Mr. Davuluri Saharsh Rao - Trustees) | Promoter | 26.03% | 0.00 |
| Malabar India Fund Limited | FII | 5.43% | −0.23 |
| Mukul Mahavir Agrawal | Public | 3.15% | 0.00 |
| Icici Prudential Balanced Advantage Fund | DII | 2.17% | New |
| Davuluri Sucheth Rao | Promoter | 2.02% | 0.00 |
| Mahindra Manulife Elss Tax Saver Fund | DII | 1.94% | +0.49 |
| Siddharth Iyer | Public | 1.66% | 0.00 |
| Ramamohan Rao Davuluri | Promoter | 1.62% | 0.00 |
| Hsbc Mutual Fund - Hsbc Small Cap Fund | DII | 1.54% | −0.26 |
| Davuluri Saharsh Rao | Promoter | 1.51% | 0.00 |
| Bajaj Finserv Flexi Cap Fund | DII | 1.29% | +0.03 |
| Hdfc Mutual Fund - Hdfc Bse 500 Etf | DII | 1.29% | New |
| Jupiter India Fund | FII | 1.18% | −0.10 |
| Kedia Securities Private Limited | Public | 1.02% | 0.00 |
| Davuluri Rohini Niveditha Rao | Promoter | 0.67% | 0.00 |
| Gannabathula Veeravenkata Satyanarayanamurty | Promoter | 0.24% | 0.00 |
| Usha Rani Reddy Chevalla | Promoter | 0.21% | −0.01 |
| Deepthi Davuluri | Promoter | 0.10% | 0.00 |
| G V V Sriranganayakamma | Promoter | 0.07% | 0.00 |
| Gannabathula Uma Bala | Promoter | 0.05% | 0.00 |
| Gannabathula Venkata Krishna Rama Rao | Promoter | 0.05% | 0.00 |
| Kommula Kamala Tayaramma | Promoter | 0.05% | 0.00 |
| Davuluri Vijaya Rao | Promoter | 0.04% | 0.00 |
| Icici Prudential S&P Bse 500 Etf | DII | Exited | — |
Promoters held 32.66% of Neuland Laboratories at the end of the Jun 2026 quarter, down 0.05 percentage points from 32.71% a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held 21.06% (up 0.62 percentage points from 20.44% a quarter earlier) and domestic institutions (DIIs) held 16.56% (up 0.68 percentage points from 15.88% a quarter earlier).
Yes. 2.30% of promoter shares were pledged at the end of the Jun 2026 quarter.
Neuland Laboratories had 44,325 shareholders at the end of the Jun 2026 quarter, against 42,405 a year earlier.
Malabar India Fund Limited (FII) held 5.43% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.